SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-20-014033
Filing Date
2020-12-30
Accepted
2020-12-30 17:16:49
Documents
54
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 DECEMBER 31, 2019 10-Q/A cvm_10q.htm 10-Q/A 882320
2 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex31.htm EX-32 26820
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex32.htm EX-32 7368
  Complete submission text file 0001654954-20-014033.txt   3348051

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cvm-20191231.xml EX-101.INS 543028
5 XBRL TAXONOMY EXTENSION SCHEMA cvm-20191231.xsd EX-101.SCH 47056
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20191231_cal.xml EX-101.CAL 42438
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20191231_def.xml EX-101.DEF 70287
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20191231_lab.xml EX-101.LAB 259266
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20191231_pre.xml EX-101.PRE 186923
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-11889 | Film No.: 201426643
SIC: 2836 Biological Products, (No Diagnostic Substances)